Viewing Study NCT06096805



Ignite Creation Date: 2024-05-06 @ 7:40 PM
Last Modification Date: 2024-10-26 @ 3:11 PM
Study NCT ID: NCT06096805
Status: RECRUITING
Last Update Posted: 2024-06-07
First Post: 2023-10-16

Brief Title: Prediction of Placental Fetal Growth Restriction in High Risk Population PoPFGR
Sponsor: Shanghai First Maternity and Infant Hospital
Organization: Shanghai First Maternity and Infant Hospital

Study Overview

Official Title: Prediction of Placental Fetal Growth Restriction in High Risk Population PoPFGR
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study intends to prospectively enroll high-risk pregnant women to establish a multicenter cohort By combining maternal basic characteristics medical history early pregnancy ultrasound and biological markers we aim to construct a joint predictive model for MVM-FGR
Detailed Description: Clinical guidelines do not recommend clinical screening for MVM-FGR in low-risk populations Predictive models for FGR are often based on preeclampsia prediction models or Down syndrome serum screening models which have limited utility This study aims to establish a multi-center prospective cohort of pregnant women at high risk for FGR We will collect baseline characteristics of pregnant women ultrasound measurements of fetal growth structural scans maternal-fetal Doppler blood flow as well as maternal serum and plasma in first and mid-trimester Serum and plasma biomarker testing will be conducted We will regularly observe fetal growth data maternal-fetal complications during pregnancy and collect delivery information conditions of the newborn and placental pathology results after birth By integrating maternal medical history serum and plasma biomarkers Doppler ultrasound and other factors we will establish a combined predictive model for early and mid-term MVM-FGR

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None